Nichols CI, Vose JG. Use of a saline-coupled bipolar sealer open liver resection for hepatic malignancy: Medical resource use and costs. World J Gastroenterol 2016; 22(46): 10189-10197 [PMID: 28028367 DOI: 10.3748/wjg.v22.i46.10189]
Corresponding Author of This Article
Joshua G Vose, MD, Medical Director, Medtronic Advanced Energy, 180 International Drive, Portsmouth, NH 03801, United States. joshua.vose@medtronic.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Control Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Length of stay, deviation mix and weighted average mean cost (propensity-matched cohorts)
Characteristic
SCBS
No SCBS
P value
Length of stay (LOS), d
mean (SD)
7.38 (5.18)
8.18 (7.27)
0.210
25th percentile
4
4
Median
6
6
75th percentile
8
8
Deviation mix, n (%)
On course
77 (53.5)
302 (41.9)
0.013
Minor deviation
30 (20.8)
187 (26.0)
0.208
Moderate deviation
28 (19.4)
150 (20.8)
0.821
Major deviation
9 (6.3)
81 (11.3)
0.074
mean (SD) total hospital cost
On course
18000 (5746)
16813 (6588)
0.029
Minor deviation
28379 (14863)
25452 (11186)
0.454
Moderate deviation
36558 (17777)
35261 (19390)
0.571
Major deviation
45717 (19045)
49082 (35303)
0.568
WAMC total hospitalization cost
$25503
$26530
WAMC difference
$1027
Table 5 Logistic regressions of predictors of topical hemostat use and transfusion
Parameter
Predictors of topical hemostat use
Predictors of transfusion
Odds ratio
95%CI
P value
Odds ratio
95%CI
P value
Age group (vs 18 to 44)
75 plus
1.03
0.50-2.12
0.421
4.55
1.95-10.59
< 0.0001
Race (vs caucasian)
Black
1.21
0.75-1.97
0.275
1.97
1.21-3.19
0.017
United States geographic region (vs northeast)
South
3.67
2.38-5.65
0.0004
1.87
1.19-2.96
0.001
Partial hepatectomy (vs lobectomy)
1.25
0.91-1.73
0.175
1.62
1.16-2.27
0.005
Primary malignancy (vs metastatic)
0.80
0.53-1.20
0.281
1.54
1.00-2.38
0.050
Provider specialty (vs general surgery)
Surgical oncology
0.30
0.20-0.46
< 0.0001
0.65
0.42-1.01
0.005
Other specialty
0.68
0.40-1.16
0.402
1.48
0.85-2.57
0.023
Case cohort (vs matched controls)
2.56
1.70-3.86
< 0.0001
0.44
0.27-0.71
0.0008
Topical hemostat use
N/A
N/A
N/A
1.87
1.33-2.64
0.0004
Citation: Nichols CI, Vose JG. Use of a saline-coupled bipolar sealer open liver resection for hepatic malignancy: Medical resource use and costs. World J Gastroenterol 2016; 22(46): 10189-10197